(S)-1-(4-fluoro-1-methyl-1H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-3-yl)-1,3-dihydro-2H-imidazol-2-one hydrochloride

(S)-1-(4-fluoro-1-methyl-1H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-3-yl)-1,3-dihydro-2H-imidazol-2-one hydrochloride
Product Description

Orforglipron intermediates

Chongqing Quanxinxiangsheng Bio-Pharmaceutical Co., Ltd.

  • Country/Region:
    China
  • On CPHI since:
    2019
  • Certificates:
    1
  • Employees:
    50 - 99
Company types
Biopharmaceutical company
Manufacturer/Innovator
Primary activities
API Producer
Biopharmaceutical
Specifications
  • CAS Registry Number
    2212022-57-4
  • Details
    Orforglipron intermediates
  • Selling Points
    Enbridge plant produce

Chongqing Quanxinxiangsheng Bio-Pharmaceutical Co., Ltd.

  • Country/Region:
    China
  • On CPHI since:
    2019
  • Certificates:
    1
  • Employees:
    50 - 99
Company types
Biopharmaceutical company
Manufacturer/Innovator
Primary activities
API Producer
Biopharmaceutical

More Products from Chongqing Quanxinxiangsheng Bio-Pharmaceutical Co., Ltd. (99)